Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

4 Oversold Large Cap Stocks Yielding High Dividends: https://www.marketbeat.com/logos/articles/med_20240313190843_4-oversold-large-cap-stocks-yielding-high-dividend.jpg
4 Oversold Large Cap Stocks Yielding High Dividends

As the market continues its relentless ascent to new heights, propelled by the surging tech sector and hype surrounding AI,  the murmurs of potential interest rate cuts by the Federal Reserve

Big Investors Like What Comcast, Schwab, Alphabet Have to Offer: https://www.marketbeat.com/logos/articles/med_20240313185402_big-investors-like-what-comcast-schwab-alphabet-ha.jpg
Big Investors Like What Comcast, Schwab, Alphabet Have to Offer

Comcast Corp. (NASDAQ: CMCSA), Charles Schwab Corp. (NYSE: SCHW) and Alphabet Inc. (NASDAQ: GOOGL) are among institutional-quality large-cap stocks that are currently undervalued.

There are a few

3 Small-Cap Leaders Poised for Significant Growth: https://www.marketbeat.com/logos/articles/med_20240312114211_3-small-cap-leaders-poised-for-significant-growth.jpg
3 Small-Cap Leaders Poised for Significant Growth

They may not be household names like Meta Platforms Inc. (NASDAQ: META) or investor favorites like Nvidia Corp. (NASDAQ: NVDA), but several small stocks, such as Ultra Clean Holdings, Inc.

Eilt: Völlig neue Krebsbehandlung - Hautkrebs vollständig geheilt. Diesen Biotech Hot Stock jetzt kaufen nach 9.290% mit Novo-Nordisk ($NVO): https://www.irw-press.at/prcom/images/messages/2024/73926/AC_Vidac_130324.001.png
Eilt: Völlig neue Krebsbehandlung - Hautkrebs vollständig geheilt. Diesen Biotech Hot Stock jetzt kaufen nach 9.290% mit Novo-Nordisk ($NVO)

Eilt: Völlig neue Krebsbehandlung - Hautkrebs vollständig geheilt. Diesen Biotech Hot Stock jetzt kaufen nach 9.290%

 

13.03.24 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Eilt: Studie für völlig neue Krebsbehandlung genehmigt. Neuer 797% Biotech Hot Stock nach 15.973% mit BioNTech ($BNTX): https://www.irw-press.at/prcom/images/messages/2024/73909/aktiencheck120324.001.png
Eilt: Studie für völlig neue Krebsbehandlung genehmigt. Neuer 797% Biotech Hot Stock nach 15.973% mit BioNTech ($BNTX)

Eilt: Studie für völlig neue Krebsbehandlung genehmigt. Neuer 797% Biotech Hot Stock nach 15.973% mit BioNTech ($BNTX)

 

12.03.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Link

Another 20% Upside for Broadcom Stock: Analysts Say Buy the Dip: https://www.marketbeat.com/logos/articles/med_20240311080123_chart-avgo-3112024ver001.png
Another 20% Upside for Broadcom Stock: Analysts Say Buy the Dip

The price action in Broadcom Inc. (NASDAQ: AVGO) began correcting after its FQ1 earnings release, and it may move lower, but this is a near-term phenomenon investors should embrace. Broadcom's

Micron Stock: Why $100 per Share is Just the Start: https://www.marketbeat.com/logos/articles/med_20240308090853_micron-stock-why-100-per-share-is-just-the-start.jpg
Micron Stock: Why $100 per Share is Just the Start

With shares of Micron Technology Inc. (NASDAQ: MU) trading up just over 1% in Friday's premarket session, it looks like the company will end the week on a high note. 

Yesterday's 3.5% pop set the

Apple Enters Oversold Territory, Time to Buy?: https://www.marketbeat.com/logos/articles/med_20240308083921_apple-enters-oversold-territory-time-to-buy.jpg
Apple Enters Oversold Territory, Time to Buy?

Shares of the hardware and software consumer products giant Apple (NASDAQ: AAPL) have had a year to forget. The company’s stock has fallen over 12% year-to-date, bringing its one-year performance

Microsoft Stock and The Case For A $500 Price Tag: https://www.marketbeat.com/logos/articles/med_20240308080209_microsoft-stock-and-the-case-for-a-500-price-tag.jpg
Microsoft Stock and The Case For A $500 Price Tag

With equities, in general, enjoying their best run in years, it will be no surprise to most that the tech stocks, in particular, are performing well. Much of this has to do with encouraging signs

Eilt: Hautkrebs vollständig geheilt - Blockbuster gegen Hautkrebs. Neuer 797% Biotech Aktientip nach 15.973% mit BioNTech ($BNTX): https://www.irw-press.at/prcom/images/messages/2024/73877/AC-080324.001.png
Eilt: Hautkrebs vollständig geheilt - Blockbuster gegen Hautkrebs. Neuer 797% Biotech Aktientip nach 15.973% mit BioNTech ($BNTX)

Eilt: Hautkrebs vollständig geheilt - Blockbuster gegen Hautkrebs. Neuer 797% Biotech Aktientip nach 15973% mit BioNTech

 

08.03.24 08:03

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

Okta Raises EPS Forecasts Despite High Profile Security Breaches: https://www.marketbeat.com/logos/articles/med_20240303140829_charts-okta.jpg
Okta Raises EPS Forecasts Despite High Profile Security Breaches

Okta Inc. (NASDAQ: OKTA) is a cybersecurity company that specializes in identity and access management (IAM) solutions. The computer and technology sector firm helps companies protect against

Eilt: Durchbruch in der Krebsforschung - Hautkrebs vollständig geheilt. 661% Biotech Hot Stock nach 15.973% mit Biotech ($BNTX): https://www.irw-press.at/prcom/images/messages/2024/73865/AC-070324.001.png
Eilt: Durchbruch in der Krebsforschung - Hautkrebs vollständig geheilt. 661% Biotech Hot Stock nach 15.973% mit Biotech ($BNTX)

Eilt: Durchbruch in der Krebsforschung - Hautkrebs vollständig geheilt. 661% Biotech Hot Stock nach 134.452% mit Biogen

 

07.03.24 08:02

AC Research

 

London (www.aktiencheck.de , Anzeige)

 

CrowdStrikes’s Stock Price Will Hit $500 Soon: https://www.marketbeat.com/logos/articles/med_20240306080204_chart-crwd-362024ver001.png
CrowdStrikes’s Stock Price Will Hit $500 Soon

The price action in CrowdStrike (NASDAQ: CRWD) stock is up 25% following the Q4 release and 2024 guidance, but the rally is not over yet. The results and outlook confirm the company’s momentum is

Higher Highs are Fast Approaching for AMD Stock: https://www.marketbeat.com/logos/articles/med_20240306080319_higher-highs-are-fast-approaching-for-amd-stock.jpg
Higher Highs are Fast Approaching for AMD Stock

While Advanced Micro Devices (NASDAQ: AMD) might not always steal the spotlight like its competitor Nvidia (NASDAQ: NVDA), investors in this global semiconductor powerhouse have plenty to cheer

Bargain Alert: Alphabet Stock Won’t Be This Cheap For Long: https://www.marketbeat.com/logos/articles/med_20240305150213_bargain-alert-alphabet-stock-wont-be-this-cheap-fo.jpg
Bargain Alert: Alphabet Stock Won’t Be This Cheap For Long

While it managed to tag a fresh all-time high in January, shares of Alphabet Inc (NASDAQ: GOOGL) have been trading softly in the weeks since. It’s a usual divergence from the broader market, given

Institutions are Buying Broadcom Stock, a 30% Discount to Nvidia: https://www.marketbeat.com/logos/articles/med_20240305135240_institutions-are-buying-broadcom-stock-a-30-discou.jpg
Institutions are Buying Broadcom Stock, a 30% Discount to Nvidia

Everyone in the market is excited about the new breakouts in the technology stock space, with a particular focus on names like NVIDIA (NASDAQ: NVDA), termed the king of the pack. After breaking

Apple Scraps EV Plans: Here’s What’s Next, Lower Prices: https://www.marketbeat.com/logos/articles/med_20240305125731_chart-aapl-352024ver001.png
Apple Scraps EV Plans: Here’s What’s Next, Lower Prices

Unsurprisingly, Apple (NASDAQ: AAPL) scrapped its plans to build an electric vehicle. After ten years of effort, the goal to launch a 100% autonomous vehicle in 2024 failed to produce even a

Biotech Hot Stock 2024: Erstklassige Studienergebnisse - Hautkrebs vollständig geheilt. Diese Biotech-Aktie jetzt kaufen nach 15.973% mit Biotech ($BNTX): https://www.irw-press.at/prcom/images/messages/2024/73854/AC_Vidac_060324.001.png
Biotech Hot Stock 2024: Erstklassige Studienergebnisse - Hautkrebs vollständig geheilt. Diese Biotech-Aktie jetzt kaufen nach 15.973% mit Biotech ($BNTX)

Biotech Hot Stock 2024: Erstklassige Studienergebnisse - Hautkrebs vollständig geheilt. Diese Biotech-Aktie jetzt kaufen

 

06.03.24 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

Eilt: 95% weniger Medikamente - 100 mal wirksamer gegen Krebs. Neuer 503% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73839/acresearch050324.001.png
Eilt: 95% weniger Medikamente - 100 mal wirksamer gegen Krebs. Neuer 503% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: 95% weniger Medikamente - 100 mal wirksamer gegen Krebs. Neuer 503% Biotech Hot Stock nach 9.290% mit Novo-Nordisk

 

05.03.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Eilt: 100 mal wirksamer gegen Krebs - Großinvestoren unmittelbar vor Einstieg. Neuer 503% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73815/AC-040324.001.png
Nvidia's Soaring Success: Too Late to Buy?: https://www.marketbeat.com/logos/articles/med_20240301081214_nvidias-soaring-success-too-late-to-buy.jpg
Nvidia's Soaring Success: Too Late to Buy?

At the forefront of the market surge stands Nvidia (NASDAQ: NVDA), continuing its meteoric rise into the new year. Last year’s champion stock has wasted no time in extending its winning streak,

3 Stocks Showing Constructive Pullbacks with Indexes at New Highs: https://www.marketbeat.com/logos/articles/med_20240301101105_3-stocks-showing-constructive-pullbacks-with-index.jpg
3 Stocks Showing Constructive Pullbacks with Indexes at New Highs

One of the most exciting things for an investor or trader is to look at tier account statement, or at the charts of what they own, and see a stock like Nvidia Corp. (NASDAQ: NVDA) or even the

Zscaler Stock Price Plunges: Buy the Dip Candidate: https://www.marketbeat.com/logos/articles/med_20240301074904_chart-zs-312024ver001.png
Zscaler Stock Price Plunges: Buy the Dip Candidate

Zscaler (NASDAQ: ZS) had a robust Q2 and raised its guidance, but it was not enough to lift the market. The results and valuation suggest the stock is priced to perfection following the

Eilt: Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 503% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73797/AC-010324.001.png
Eilt: Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 503% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. 503% Biotech Aktientip nach 134.452% mit Biogen

 

01.03.24 08:03

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Salesforce.com Stock Will Set a New High This Year: https://www.marketbeat.com/logos/articles/med_20240229093245_chart-crm-2292024ver001.png
Salesforce.com Stock Will Set a New High This Year

Salesforce.com’s (NYSE: CRM) stock price is having trouble with traction following the Q4 results and guidance, but a massive correction is not expected for this tech stock. The results did not